1,2-dimethylhydrazine decreases expression ISO RGD:1332205 6480464 1, 2-Dimethylhydrazine results in decreased expression of ELOVL6 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1332205 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ELOVL6 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ELOVL6 mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO RGD:1332205 6480464 Ethinyl Estradiol results in increased expression of ELOVL6 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ELOVL6 mRNA CTD PMID:17351261 17alpha-ethynylestradiol multiple interactions ISO RGD:1332205 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ELOVL6 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1332205 6480464 Estradiol results in decreased expression of ELOVL6 mRNA CTD PMID:19484750 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ELOVL6 mRNA CTD PMID:35192832 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ELOVL6 protein CTD PMID:23180365 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1332205 6480464 2 more ... CTD PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:1332205 6480464 2 more ... CTD PMID:20005886 , PMID:21851831 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1332205 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1332205 6480464 2 more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ELOVL6 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1332205 6480464 Tetrachlorodibenzodioxin results in decreased expression of ELOVL6 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ELOVL6 mRNA CTD PMID:23238561 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ELOVL6 mRNA CTD PMID:18796159 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332205 6480464 Tetrachlorodibenzodioxin affects the expression of ELOVL6 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1345221 6480464 Tetrachlorodibenzodioxin results in decreased expression of ELOVL6 mRNA CTD PMID:20106945 , PMID:21632981 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ELOVL6 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ELOVL6 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:1332205 6480464 Glucosamine results in increased expression of ELOVL6 mRNA CTD PMID:17178593 2-butoxyethanol decreases expression ISO RGD:1332205 6480464 n-butoxyethanol results in decreased expression of ELOVL6 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:1345221 6480464 beta-methylcholine affects the expression of ELOVL6 mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of ELOVL6 mRNA CTD PMID:27914987 3,4-dichloroaniline decreases expression EXP 6480464 3, 4-dichloroaniline results in decreased expression of ELOVL6 mRNA CTD PMID:24172598 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ELOVL6 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1332205 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL6 mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1345221 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELOVL6 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:1332205 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ELOVL6 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:1332205 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of ELOVL6 mRNA CTD PMID:33297965 5-bromo-2'-deoxyuridine increases expression ISO RGD:1332205 6480464 Bromodeoxyuridine results in increased expression of ELOVL6 mRNA CTD PMID:24910943 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression ISO RGD:1345221 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ELOVL6 mRNA CTD PMID:24780913 aflatoxin B1 decreases expression ISO RGD:1332205 6480464 Aflatoxin B1 results in decreased expression of ELOVL6 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression ISO RGD:1345221 6480464 Aflatoxin B1 results in decreased expression of ELOVL6 mRNA CTD PMID:21641981 , PMID:27153756 aflatoxin B1 multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of ELOVL6 mRNA CTD PMID:25450479 aldehydo-D-glucosamine increases expression ISO RGD:1332205 6480464 Glucosamine results in increased expression of ELOVL6 mRNA CTD PMID:17178593 aldehydo-D-glucose multiple interactions ISO RGD:1345221 6480464 (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA] more ... CTD PMID:32613381 aldehydo-D-glucose increases expression ISO RGD:1332205 6480464 Glucose results in increased expression of ELOVL6 mRNA CTD PMID:15066988 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of ELOVL6 mRNA CTD PMID:16790840 all-trans-retinoic acid increases expression ISO RGD:1345221 6480464 Tretinoin results in increased expression of ELOVL6 mRNA CTD PMID:33167477 amiodarone increases expression ISO RGD:1332205 6480464 Amiodarone results in increased expression of ELOVL6 mRNA CTD PMID:24489787 amiodarone increases expression ISO RGD:1345221 6480464 Amiodarone results in increased expression of ELOVL6 mRNA CTD PMID:29248575 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ELOVL6 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:1345221 6480464 aristolochic acid I results in decreased expression of ELOVL6 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1332205 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ELOVL6 mRNA CTD PMID:23650126 Azaspiracid increases expression ISO RGD:1345221 6480464 azaspiracid results in increased expression of ELOVL6 mRNA CTD PMID:28939011 benzalkonium chloride increases expression ISO RGD:1332205 6480464 Benzalkonium Compounds results in increased expression of ELOVL6 mRNA CTD PMID:31199489 benzene increases expression ISO RGD:1345221 6480464 Benzene results in increased expression of ELOVL6 mRNA CTD PMID:20359517 benzo[a]pyrene decreases expression ISO RGD:1345221 6480464 Benzo(a)pyrene results in decreased expression of ELOVL6 mRNA CTD PMID:20064835 more ... benzo[a]pyrene increases methylation ISO RGD:1345221 6480464 Benzo(a)pyrene results in increased methylation of ELOVL6 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1332205 6480464 Benzo(a)pyrene results in decreased expression of ELOVL6 mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1345221 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 Benzo[k]fluoranthene decreases expression ISO RGD:1332205 6480464 benzo(k)fluoranthene results in decreased expression of ELOVL6 mRNA CTD PMID:26377693 beta-D-glucosamine increases expression ISO RGD:1332205 6480464 Glucosamine results in increased expression of ELOVL6 mRNA CTD PMID:17178593 beta-naphthoflavone decreases expression ISO RGD:1345221 6480464 beta-Naphthoflavone results in decreased expression of ELOVL6 mRNA CTD PMID:31225620 bexarotene multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of ELOVL6 mRNA CTD PMID:17630414 bezafibrate multiple interactions ISO RGD:1345221 6480464 [Oleic Acid co-treated with Bezafibrate] results in increased expression of ELOVL6 mRNA CTD PMID:24534255 bisphenol A increases expression ISO RGD:1332205 6480464 bisphenol A results in increased expression of ELOVL6 mRNA CTD PMID:21932408 , PMID:35341816 bisphenol A decreases expression ISO RGD:1332205 6480464 bisphenol A results in decreased expression of ELOVL6 mRNA CTD PMID:32156529 bisphenol A decreases methylation ISO RGD:1332205 6480464 bisphenol A results in decreased methylation of ELOVL6 promoter CTD PMID:27312807 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ELOVL6 mRNA CTD PMID:30816183 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ELOVL6 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1345221 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELOVL6 mRNA CTD PMID:28628672 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of ELOVL6 mRNA CTD PMID:24136188 butan-1-ol multiple interactions ISO RGD:1345221 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ELOVL6 mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:1345221 6480464 butyraldehyde results in decreased expression of ELOVL6 mRNA CTD PMID:26079696 captan increases expression ISO RGD:1332205 6480464 Captan results in increased expression of ELOVL6 mRNA CTD PMID:31558096 carbon nanotube decreases expression ISO RGD:1332205 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube affects expression ISO RGD:1332205 6480464 Nanotubes, Carbon analog affects the expression of ELOVL6 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1332205 6480464 Nanotubes, Carbon results in increased expression of ELOVL6 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1345221 6480464 CGP 52608 promotes the reaction [RORA protein binds to ELOVL6 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1332205 6480464 Chlordecone results in increased expression of ELOVL6 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:1332205 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of ELOVL6 mRNA more ... CTD PMID:20938992 , PMID:29246445 cisplatin decreases expression ISO RGD:1345221 6480464 Cisplatin results in decreased expression of ELOVL6 mRNA CTD PMID:19561079 , PMID:27594783 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of ELOVL6 mRNA CTD PMID:27665778 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ELOVL6 mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:1345221 6480464 cobaltous chloride results in decreased expression of ELOVL6 mRNA CTD PMID:19376846 , PMID:22941251 copper atom decreases expression ISO RGD:1332205 6480464 Copper results in decreased expression of ELOVL6 mRNA CTD PMID:17205981 copper(0) decreases expression ISO RGD:1332205 6480464 Copper results in decreased expression of ELOVL6 mRNA CTD PMID:17205981 copper(II) chloride decreases expression ISO RGD:1345221 6480464 cupric chloride results in decreased expression of ELOVL6 mRNA CTD PMID:34921933 copper(II) sulfate decreases expression ISO RGD:1345221 6480464 Copper Sulfate results in decreased expression of ELOVL6 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1345221 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1345221 6480464 Coumestrol results in increased expression of ELOVL6 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:1332205 6480464 Asbestos, Crocidolite results in decreased expression of ELOVL6 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ELOVL6 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1332205 6480464 Cyclosporine results in decreased expression of ELOVL6 mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:1345221 6480464 Cyclosporine results in increased expression of ELOVL6 mRNA CTD PMID:27989131 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ELOVL6 mRNA CTD PMID:19224547 cyclosporin A decreases expression ISO RGD:1345221 6480464 Cyclosporine results in decreased expression of ELOVL6 mRNA CTD PMID:20106945 , PMID:25562108 D-glucose multiple interactions ISO RGD:1345221 6480464 (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA] more ... CTD PMID:32613381 D-glucose increases expression ISO RGD:1332205 6480464 Glucose results in increased expression of ELOVL6 mRNA CTD PMID:15066988 D-glucose increases expression EXP 6480464 Glucose results in increased expression of ELOVL6 mRNA CTD PMID:16790840 dexamethasone increases expression ISO RGD:1345221 6480464 Dexamethasone results in increased expression of ELOVL6 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1345221 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELOVL6 mRNA CTD PMID:28628672 dexamethasone multiple interactions ISO RGD:1332205 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL6 mRNA CTD PMID:16054899 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ELOVL6 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:1332205 6480464 Dichloroacetic Acid results in increased expression of ELOVL6 mRNA CTD PMID:28962523 dichloromethane increases expression ISO RGD:1345221 6480464 Methylene Chloride results in increased expression of ELOVL6 mRNA CTD PMID:20359517 diclofenac increases expression ISO RGD:1332205 6480464 Diclofenac results in increased expression of ELOVL6 mRNA CTD PMID:35537566 dicrotophos decreases expression ISO RGD:1345221 6480464 dicrotophos results in decreased expression of ELOVL6 mRNA CTD PMID:28302478 dioxygen decreases expression ISO RGD:1332205 6480464 Oxygen deficiency results in decreased expression of ELOVL6 mRNA CTD PMID:20880076 dioxygen decreases expression ISO RGD:1345221 6480464 Oxygen deficiency results in decreased expression of ELOVL6 mRNA CTD PMID:26516004 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ELOVL6 mRNA CTD PMID:21551480 Enterolactone multiple interactions ISO RGD:1345221 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA CTD PMID:19167446 epoxiconazole decreases expression ISO RGD:1332205 6480464 epoxiconazole results in decreased expression of ELOVL6 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1345221 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ELOVL6 mRNA CTD PMID:29432896 ethyl methanesulfonate decreases expression ISO RGD:1345221 6480464 Ethyl Methanesulfonate results in decreased expression of ELOVL6 mRNA CTD PMID:23649840 ethylbenzene increases expression ISO RGD:1345221 6480464 ethylbenzene results in increased expression of ELOVL6 mRNA CTD PMID:20359517 farnesol multiple interactions ISO RGD:1345221 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of ELOVL6 mRNA CTD PMID:30611723 fenofibrate multiple interactions ISO RGD:1345221 6480464 [Oleic Acid co-treated with Fenofibrate] affects the expression of ELOVL6 mRNA CTD PMID:24534255 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of ELOVL6 mRNA CTD PMID:27665778 fenofibrate increases expression ISO RGD:1332205 6480464 Fenofibrate results in increased expression of ELOVL6 mRNA CTD PMID:23063693 fenofibrate multiple interactions ISO RGD:1332205 6480464 NR1H2 gene mutant form inhibits the reaction [Fenofibrate results in increased expression of ELOVL6 mRNA] more ... CTD PMID:23063693 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of ELOVL6 mRNA CTD PMID:30307764 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of ELOVL6 mRNA CTD PMID:18035473 fluoranthene multiple interactions ISO RGD:1332205 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ELOVL6 mRNA CTD PMID:28329830 fluoranthene decreases expression ISO RGD:1332205 6480464 fluoranthene results in decreased expression of ELOVL6 mRNA CTD PMID:28329830 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of ELOVL6 mRNA CTD PMID:28677866 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ELOVL6 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1332205 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folpet increases expression ISO RGD:1332205 6480464 folpet results in increased expression of ELOVL6 mRNA CTD PMID:31558096 formaldehyde decreases expression ISO RGD:1345221 6480464 Formaldehyde results in decreased expression of ELOVL6 mRNA CTD PMID:23649840 fructose increases expression ISO RGD:1332205 6480464 Fructose results in increased expression of ELOVL6 mRNA CTD PMID:15066988 furan increases expression EXP 6480464 furan results in increased expression of ELOVL6 mRNA CTD PMID:25539665 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of ELOVL6 mRNA CTD PMID:27665778 glafenine increases expression EXP 6480464 Glafenine results in increased expression of ELOVL6 mRNA CTD PMID:24136188 glucose multiple interactions ISO RGD:1345221 6480464 (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA] more ... CTD PMID:32613381 glucose increases expression EXP 6480464 Glucose results in increased expression of ELOVL6 mRNA CTD PMID:16790840 glucose increases expression ISO RGD:1332205 6480464 Glucose results in increased expression of ELOVL6 mRNA CTD PMID:15066988 GW 4064 multiple interactions ISO RGD:1345221 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ELOVL6 mRNA CTD PMID:30611723 Heptachlor epoxide increases expression ISO RGD:1332205 6480464 Heptachlor Epoxide results in increased expression of ELOVL6 mRNA CTD PMID:25270620 hexadecanoic acid multiple interactions ISO RGD:1345221 6480464 (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA] more ... CTD PMID:30547786 , PMID:32613381 hydralazine multiple interactions ISO RGD:1345221 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ELOVL6 mRNA CTD PMID:17183730 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1332205 6480464 indeno(1 more ... CTD PMID:26377693 indometacin multiple interactions ISO RGD:1345221 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELOVL6 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:1332205 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ELOVL6 mRNA CTD PMID:36331819 isobutanol multiple interactions ISO RGD:1345221 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ELOVL6 mRNA CTD PMID:29432896 L-methionine multiple interactions ISO RGD:1332205 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ELOVL6 mRNA CTD PMID:20938992 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of ELOVL6 mRNA CTD PMID:28801915 mercury dichloride increases response to substance ISO RGD:1345221 6480464 ELOVL6 protein results in increased susceptibility to Mercuric Chloride CTD PMID:24118919 mercury dichloride affects expression ISO RGD:1345221 6480464 Mercuric Chloride affects the expression of ELOVL6 mRNA CTD PMID:24118919 metformin decreases expression ISO RGD:1345221 6480464 Metformin results in decreased expression of ELOVL6 protein CTD PMID:28576465 metformin affects expression EXP 6480464 Metformin affects the expression of ELOVL6 mRNA CTD PMID:31324951 methyl methanesulfonate decreases expression ISO RGD:1345221 6480464 Methyl Methanesulfonate results in decreased expression of ELOVL6 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1345221 6480464 methylmercuric chloride results in decreased expression of ELOVL6 mRNA CTD PMID:24118919 methylparaben decreases expression ISO RGD:1345221 6480464 methylparaben results in decreased expression of ELOVL6 mRNA CTD PMID:31745603 monosodium L-glutamate multiple interactions ISO RGD:1332205 6480464 3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine affects the reaction [[Dietary Fats co-treated with Sodium Glutamate] affects the expression of ELOVL6 mRNA], [Dietary Fats co-treated with Sodium Glutamate] affects the expression of ELOVL6 mRNA CTD PMID:26670228 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of ELOVL6 mRNA CTD PMID:21515302 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ELOVL6 mRNA CTD PMID:28801915 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of ELOVL6 mRNA CTD PMID:16525678 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of ELOVL6 mRNA CTD PMID:22110744 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of ELOVL6 mRNA CTD PMID:24136188 o-xylene increases expression ISO RGD:1345221 6480464 2-xylene results in increased expression of ELOVL6 mRNA CTD PMID:20359517 obeticholic acid decreases expression ISO RGD:1345221 6480464 obeticholic acid results in decreased expression of ELOVL6 mRNA CTD PMID:27939613 oleic acid multiple interactions ISO RGD:1345221 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of ELOVL6 mRNA more ... CTD PMID:24534255 more ... paracetamol affects expression ISO RGD:1332205 6480464 Acetaminophen affects the expression of ELOVL6 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1345221 6480464 Acetaminophen results in decreased expression of ELOVL6 mRNA CTD PMID:21420995 more ... paracetamol increases expression ISO RGD:1332205 6480464 Acetaminophen results in increased expression of ELOVL6 mRNA CTD PMID:26522476 perfluorononanoic acid decreases expression ISO RGD:1345221 6480464 perfluoro-n-nonanoic acid results in decreased expression of ELOVL6 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1345221 6480464 perfluorooctane sulfonic acid results in decreased expression of ELOVL6 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1332205 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ELOVL6 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ELOVL6 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of ELOVL6 mRNA CTD PMID:18692542 perfluorooctanoic acid increases expression ISO RGD:1345221 6480464 perfluorooctanoic acid results in increased expression of ELOVL6 mRNA CTD PMID:25868421 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ELOVL6 mRNA CTD PMID:16221955 perfluorooctanoic acid increases expression ISO RGD:1332205 6480464 perfluorooctanoic acid results in increased expression of ELOVL6 mRNA CTD PMID:18467677 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of ELOVL6 mRNA CTD PMID:31324951 phenobarbital affects expression ISO RGD:1332205 6480464 Phenobarbital affects the expression of ELOVL6 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:1332205 6480464 Phenobarbital results in increased expression of ELOVL6 mRNA CTD PMID:25270620 pirinixic acid increases expression ISO RGD:1332205 6480464 pirinixic acid results in increased expression of ELOVL6 mRNA CTD PMID:16790840 , PMID:18467677 pirinixic acid increases activity EXP 6480464 pirinixic acid results in increased activity of ELOVL6 protein CTD PMID:15654130 pirinixic acid multiple interactions ISO RGD:1345221 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ELOVL6 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1332205 6480464 pirinixic acid results in decreased expression of ELOVL6 mRNA CTD PMID:18445702 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ELOVL6 mRNA CTD PMID:15654130 , PMID:27665778 pirinixic acid multiple interactions ISO RGD:1332205 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of ELOVL6 mRNA], PPARA protein promotes the reaction [pirinixic acid results in increased expression of ELOVL6 mRNA] CTD PMID:16790840 , PMID:18467677 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1332205 6480464 Pregnenolone Carbonitrile results in increased expression of ELOVL6 mRNA CTD PMID:28903501 progesterone increases expression EXP 6480464 Progesterone results in increased expression of ELOVL6 protein CTD PMID:23180365 progesterone increases expression ISO RGD:1345221 6480464 Progesterone results in increased expression of ELOVL6 mRNA CTD PMID:18070364 propiconazole increases expression ISO RGD:1332205 6480464 propiconazole results in increased expression of ELOVL6 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:1345221 6480464 Quercetin results in decreased expression of ELOVL6 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1345221 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of ELOVL6 mRNA, [Plant Extracts co-treated with Resveratrol] results in increased expression of ELOVL6 mRNA CTD PMID:19167446 , PMID:23557933 resveratrol increases expression ISO RGD:1332205 6480464 resveratrol results in increased expression of ELOVL6 protein CTD PMID:25505154 ritodrine increases expression ISO RGD:1332205 6480464 Ritodrine results in increased expression of ELOVL6 mRNA CTD PMID:23370008 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ELOVL6 mRNA CTD PMID:28374803 saroglitazar multiple interactions ISO RGD:1345221 6480464 saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA] CTD PMID:32613381 sodium dichromate increases expression ISO RGD:1332205 6480464 sodium bichromate results in increased expression of ELOVL6 mRNA CTD PMID:31558096 Sodium oleate multiple interactions ISO RGD:1345221 6480464 (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA] more ... CTD PMID:32613381 Soman decreases expression EXP 6480464 Soman results in decreased expression of ELOVL6 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1332205 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ELOVL6 mRNA CTD PMID:21641980 sulforaphane multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of ELOVL6 mRNA CTD PMID:25450479 sulforaphane increases expression ISO RGD:1345221 6480464 sulforaphane results in increased expression of ELOVL6 mRNA CTD PMID:31838189 tamoxifen affects expression ISO RGD:1332205 6480464 Tamoxifen affects the expression of ELOVL6 mRNA CTD PMID:20937368 tamoxifen multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of ELOVL6 mRNA CTD PMID:17630414 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of ELOVL6 mRNA CTD PMID:21515302 Tesaglitazar multiple interactions ISO RGD:1345221 6480464 [Oleic Acid co-treated with tesaglitazar] results in increased expression of ELOVL6 mRNA CTD PMID:24534255 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of ELOVL6 protein CTD PMID:23180365 tetrachloromethane decreases expression ISO RGD:1332205 6480464 Carbon Tetrachloride results in decreased expression of ELOVL6 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ELOVL6 mRNA CTD PMID:19224547 , PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1332205 6480464 PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of ELOVL6 mRNA] CTD PMID:16006527 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of ELOVL6 mRNA CTD PMID:19224547 tetracycline increases expression ISO RGD:1332205 6480464 Tetracycline results in increased expression of ELOVL6 mRNA CTD PMID:16917069 toluene increases expression ISO RGD:1345221 6480464 Toluene results in increased expression of ELOVL6 mRNA CTD PMID:20359517 Tributyltin oxide increases expression ISO RGD:1332205 6480464 bis(tri-n-butyltin)oxide results in increased expression of ELOVL6 mRNA CTD PMID:25270620 trichloroethene increases expression ISO RGD:1345221 6480464 Trichloroethylene results in increased expression of ELOVL6 mRNA CTD PMID:20359517 trichloroethene increases expression ISO RGD:1332205 6480464 Trichloroethylene results in increased expression of ELOVL6 mRNA CTD PMID:19448997 trichostatin A increases expression ISO RGD:1345221 6480464 trichostatin A results in increased expression of ELOVL6 mRNA CTD PMID:24935251 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of ELOVL6 mRNA CTD PMID:30589522 Triptolide decreases expression ISO RGD:1332205 6480464 triptolide results in decreased expression of ELOVL6 mRNA CTD PMID:32835833 triptonide affects expression ISO RGD:1332205 6480464 triptonide affects the expression of ELOVL6 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1332205 6480464 troglitazone results in decreased expression of ELOVL6 mRNA CTD PMID:28973697 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of ELOVL6 mRNA CTD PMID:21515302 troglitazone decreases expression ISO RGD:1345221 6480464 troglitazone results in decreased expression of ELOVL6 mRNA CTD PMID:25572481 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of ELOVL6 mRNA CTD PMID:24136188 tungsten decreases expression ISO RGD:1332205 6480464 Tungsten results in decreased expression of ELOVL6 mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:1345221 6480464 Tunicamycin results in decreased expression of ELOVL6 mRNA CTD PMID:29453283 urethane decreases expression ISO RGD:1345221 6480464 Urethane results in decreased expression of ELOVL6 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of ELOVL6 mRNA CTD PMID:24136188 valproic acid multiple interactions ISO RGD:1345221 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ELOVL6 mRNA, NR1H3 protein affects the reaction [Valproic Acid results in increased expression of ELOVL6 mRNA] CTD PMID:17183730 , PMID:30003287 valproic acid decreases expression ISO RGD:1345221 6480464 Valproic Acid results in decreased expression of ELOVL6 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1345221 6480464 Valproic Acid affects the expression of ELOVL6 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1345221 6480464 Valproic Acid results in increased expression of ELOVL6 mRNA, Valproic Acid results in increased expression of ELOVL6 protein CTD PMID:24935251 , PMID:30003287 valproic acid affects expression ISO RGD:1332205 6480464 Valproic Acid affects the expression of ELOVL6 mRNA CTD PMID:17963808 vancomycin increases expression ISO RGD:1332205 6480464 Vancomycin results in increased expression of ELOVL6 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ELOVL6 mRNA CTD PMID:19015723 , PMID:23034163 zoledronic acid increases expression ISO RGD:1345221 6480464 zoledronic acid results in increased expression of ELOVL6 mRNA CTD PMID:24714768